Nα,Nε-Di-Boc-L-lysine Dicyclohexylammonium Salt | CAS:15098-69-8

We serve Nα,Nε-Di-Boc-L-lysine Dicyclohexylammonium Salt CAS:15098-69-8 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Nα,Nε-Di-Boc-L-lysine Dicyclohexylammonium Salt

Chemical Name:Nα,Nε-Di-Boc-L-lysine Dicyclohexylammonium Salt
CAS.NO: 15098-69-8
Molecular Formula:C28H53N3O6
Molecular Weight: 527.73700

Synonyms:
Nα,Nε-Bis(tert-butoxycarbonyl)-L-lysine Dicyclohexylammonium Salt
Boc-Lys(Boc)-OH·DCHA
Dicyclohexylamine (S)-2,6-bis((tert-butoxycarbonyl)amino)hexanoate
(2S)-2,6-bis[(2-methylpropan-2-yl)oxycarbonylamino]hexanoic acid,N-cyclohexylcyclohexanamine

Physical and Chemical Properties:
Density: /
Boiling point: 672.6ºC at 760 mmHg
Melting point: /
Flash point: 360.6ºC
Refractive index: /

Specification:
Appearance: White powder
Purity:≥99%

Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store at −20°C.Keep the container tightly closed, put it in a tight dispenser, and store in a cool, dry place.
Application:pharmaceutical intermediates.



Contact us for information like Nα,Nε-Di-Boc-L-lysine Dicyclohexylammonium Salt chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,(2S)-2,6-bis[(2-methylpropan-2-yl)oxycarbonylamino]hexanoic acid,N-cyclohexylcyclohexanamine physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Nα,Nε-Bis(tert-butoxycarbonyl)-L-lysine Dicyclohexylammonium Salt Use and application,Boc-Lys(Boc)-OH·DCHA technical grade,usp/ep/jp grade.


Related News: Active pharmaceutical ingredients affect the structure and function of the human body. Inactive ingredients in a pharmaceutical may be referred to as “bulk pharmaceutical chemicals (BPCs).”1-Bromo-4-iodonaphthalene manufacturer “Traditional medicine is a treasure of Chinese civilization embodying the wisdom of the nation and its people,” Xi said at the meeting in Beijing.2-Bromo-3-methylbutyric acid supplier We have leading expertise in strategy and operational implementation of pre-approval access programs making pharmaceutical products under clinical development available for patients and Inceptua’s clinical trial services business offers high quality clinical comparator sourcing and manufacturing services with an agile global supply chain to ensure that products are delivered exactly when needed.4,6-dibromothieno[3,4-c]furan-1,3-dione vendor Countries and territories that have confirmed cases: Thailand, Japan, Hong Kong, Singapore, Taiwan, Australia, Malaysia, Macau, Russia, France, the United States, South Korea, Germany, the United Arab Emirates, Canada, Britain, Vietnam, Italy, India, the Philippines, Nepal, Cambodia, Sri Lanka, Finland, Sweden and Spain.Australia has started denying entry to all travelers who have come from or transited through mainland China.